Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Cancer biomarkers--an invitation to the table.

Science (New York, N.Y.) - 26 May 2006

Dalton William S, Friend Stephen H

Abstract excerpt

The allure of the emerging genomic technologies in cancer is their ability to generate new biomarkers that predict how individual cancer patients will respond to various treatments. However, productive implementation of cancer biomarkers into patient care will require fundamental changes in how w...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Biotechnology
Share to Clinical Trials as Topic

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Databases, Factual

Share to Drug Industry

Share to Gene Expression Regulation, Neoplastic

Share to Genomics

Share to Proteomics

Source

Identifiers

PMID: 16728629
DOI: 10.1126/science.1125948

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-16728629-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Cancer biomarkers--an invitation to the table.PMID 16728629Read ↗

Considerations About the Use of Biomarkers in Cancer Clinical Trials.Semantic proximity Read ↗

Emerging technologies for improved stratification of cancer patients: a review of opportunities, challenges, and tools.Semantic proximity Read ↗

The promise of biomarkers in cancer screening and detection.Semantic proximity Read ↗

Biomarker Tests Need Closer Scrutiny, IOM ConcludesSemantic proximity Read ↗

The Future of Cancer Diagnosis and Treatment: Unlocking the Power of Biomarkers and Personalized Molecular-Targeted TherapiesSemantic proximity Read ↗

Cancer. Developing molecular biomarkers for cancer.Semantic proximity Read ↗

Bridging Discovery and Treatment: Cancer BiomarkerSemantic proximity Read ↗

Personalized medicine using DNA biomarkers: a reviewSemantic proximity Read ↗

Cancer biomarker discovery and validation.Semantic proximity Read ↗

Biomarkers for Early Cancer Diagnosis: Prospects for Success through the Lens of Tumor Genetics.Semantic proximity Read ↗

NCCN Task Force report: Evaluating the clinical utility of tumor markers in oncology.Semantic proximity Read ↗

Clinical Biomarkers in OncologySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.